| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/12/2008 | US7329544 Plant lesion formation suppressing gene, Sp17 and use thereof |
| 02/12/2008 | US7329543 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/12/2008 | US7329541 Zinc finger binding domains for GNN |
| 02/12/2008 | US7329540 Corneodesmosin based test and model for inflammatory disease |
| 02/12/2008 | US7329530 Chimaeric phages |
| 02/12/2008 | US7329529 Ubiqutin proteases |
| 02/12/2008 | US7329520 Reacting the peptide or protein with an enzyme that is extracted from a plant of the genus Zingiber and exhibits defructosylation action |
| 02/12/2008 | US7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 02/12/2008 | US7329513 High level constitutive production of anthrax protective antigen |
| 02/12/2008 | US7329512 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 02/12/2008 | US7329510 Containing specific DNA sequence; use in the therapy of disorders selected from human psychiatric and neurological disroders, cardiiovascular disorder, and reproductive dysfunction |
| 02/12/2008 | US7329509 Culturing a host infected with recombinant baculovirus; co-expressing interacting protein, membrane-bound receptor protein in a budded baculovirus released from host |
| 02/12/2008 | US7329505 Specific detection of proteolytic enzymes |
| 02/12/2008 | US7329501 Diagnostic for insulin resistance |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329498 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 02/12/2008 | US7329496 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 02/12/2008 | US7329494 Method of detection and quantification of cGMP by using a cGMP-visualizing probe |
| 02/12/2008 | US7329486 High-throughput assay for virus entry and drug screening |
| 02/12/2008 | US7329410 Compositions and method for WT1 specific immunotherapy |
| 02/12/2008 | US7329408 Eliciting HCV-specific antibodies |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2275259C Formulations of recombinant papillomavirus vaccines |
| 02/12/2008 | CA2268397C Magnetically activated cell sorting for production of proteins |
| 02/12/2008 | CA2258307C Method of producing heterologous short chain polypeptides by yeast with impaired yap3 protease |
| 02/12/2008 | CA2236166C Enhancer-increased gene expression in plants |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/12/2008 | CA2190802C A method of preparing and recovering proteins |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/12/2008 | CA2156273C Allogeneic vaccine and methods to synthesize same |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/12/2008 | CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160 |
| 02/12/2008 | CA2090485C Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 02/07/2008 | WO2008016854A2 Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity |
| 02/07/2008 | WO2008016431A2 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 02/07/2008 | WO2008016317A2 A sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy |
| 02/07/2008 | WO2008016314A1 Myostatin antagonists |
| 02/07/2008 | WO2008016240A1 Antimicrobial protein specific to staphylococcus aureus |
| 02/07/2008 | WO2008016221A1 Cysteine-tagged staphylococcal protein g variant |
| 02/07/2008 | WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 02/07/2008 | WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition |
| 02/07/2008 | WO2008015720A2 PEPTIDE DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 BINDING INTEGRIN α5β1, HAVING PROANGIOGENIC ACTIVITY |
| 02/07/2008 | WO2008015692A2 MOLECULAR CLONING AND SEQUENCING OF ACETYL CoA CARBOXYLASE (ACCase) GENE FROM JATROPHA CURCAS |
| 02/07/2008 | WO2008015436A2 Diabetes test |
| 02/07/2008 | WO2008015425A2 Mhc oligomers, components thereof, and methods of making the same |
| 02/07/2008 | WO2008015380A2 Integral membrane protein of the pmp-22/emp/mp20/ claudin-like family |
| 02/07/2008 | WO2008015309A1 Dendrimeric peptide construct for the prevention of foot-and-mouth disease in animals |
| 02/07/2008 | WO2008015276A1 Prostaglandin-binding pocket of ppar protein and use thereof |
| 02/07/2008 | WO2008015273A1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 02/07/2008 | WO2008015263A2 Plants having improved characteristics and a method for making the same |
| 02/07/2008 | WO2008015199A1 Chemokine antagonists |
| 02/07/2008 | WO2008014917A1 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins |
| 02/07/2008 | WO2008014574A1 Cleavage of bip by subtilase cytotoxin |
| 02/07/2008 | WO2007149560A3 Fermentation and purification of actinomadura chromoprotein and related species |
| 02/07/2008 | WO2007148971A3 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
| 02/07/2008 | WO2007147630A3 Peptides regulating the surface expression of the t cell receptor |
| 02/07/2008 | WO2007118687A3 Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| 02/07/2008 | WO2007117564A3 Clay-binding peptides and methods of use |
| 02/07/2008 | WO2007112005A3 Pc5 as a factor ix propeptide processing enzyme |
| 02/07/2008 | WO2007088531A3 Pem-3-like polypeptides, complexes, and related methods |
| 02/07/2008 | WO2007053655A3 Cell-free synthesis of membrane bound polypeptides |
| 02/07/2008 | WO2007052326B1 Method for conversion of uric acid to allantoin and related enzymes |
| 02/07/2008 | WO2007048100A3 Angio-inhibitory peptides derived from human timp-2 |
| 02/07/2008 | WO2006044063A3 Transepithelial delivery of peptides with incretin hormone activities |
| 02/07/2008 | US20080034456 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 02/07/2008 | US20080034451 Rice Pollen-Preferential Promoters And Uses Thereof |
| 02/07/2008 | US20080033151 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents |
| 02/07/2008 | US20080033149 Human anti-TNF antibodies and peptides |
| 02/07/2008 | US20080033147 Method For Producing Acylated Peptides |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |
| 02/07/2008 | US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032930 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032927 Treatment of development-related disorders |
| 02/07/2008 | US20080032924 Antifungal Peptides |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof |
| 02/07/2008 | US20080032896 Methods for identifying compounds that bind to a target |
| 02/07/2008 | US20080032418 Cell Free Assay Systems For Identifying A Substance Of Interest |
| 02/07/2008 | US20080032417 Photocleavable isotope-coded affinity tags |
| 02/07/2008 | US20080032400 elastin-like peptides (ELP) spider structure complex including multi-leg moieties comprising ELP fusion proteins capable of forming covalent disulfide bonds; employed in peptide production and purification and/or to enhance protelytic resistance of a protein or peptide moiety in a fusion construct |
| 02/07/2008 | US20080032388 Live Genetically Attenuated Malaria Vaccine |
| 02/07/2008 | US20080032386 Stabilized Proline Transporter |
| 02/07/2008 | US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon |
| 02/07/2008 | US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080032339 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection |
| 02/07/2008 | US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled |
| 02/07/2008 | US20080032333 Polynucleotides encoding soluble zalpha11 cytokine receptors |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | US20080032331 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 02/07/2008 | US20080032323 Nucleic Acid Construct Containing a Nucleic Acid Derived From the Genome of Hepatitis C Virus (Hcv) of Genotype 2A, and a Cell Having Such Nucleic Acid Construct Introduced Therein |
| 02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
| 02/07/2008 | US20080032318 Fret protease assays for clostridial toxins |